Actively Recruiting

Phase Not Applicable
Age: 22Years - 70Years
All Genders
NCT07588243

A Pivotal Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Led by CynosureLutronic · Updated on 2026-05-14

44

Participants Needed

2

Research Sites

40 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.

CONDITIONS

Official Title

A Pivotal Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Who Can Participate

Age: 22Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 22 and 70 years old
  • Willing to undergo study device use
  • Fitzpatrick skin type I through VI
  • Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II)
  • Willing to avoid significant hair changes such as drastic haircuts or hair dye during the study
  • Willing to maintain current diet and exercise routines throughout the study
  • Understands and agrees to not receive other hair growth treatments, medications, or procedures during the study
  • Able to attend all study visits
  • Willing to comply with study requirements and provide written informed consent
Not Eligible

You will not qualify if you...

  • Female participants who are pregnant, have been pregnant in the last 3 months, are breastfeeding, or planning pregnancy during the study
  • Diagnosis of other types of alopecia such as scarring alopecia or alopecia areata
  • Use of systemic hair growth medications within 6 months prior to study
  • Inconsistent use of vitamins affecting hair growth; must be stable for at least 6 months prior to first treatment
  • Previous scalp treatments like laser or topical within 6 months
  • Presence of malignant disease, cancer, or uncontrolled medical conditions
  • Impaired immune system due to diseases like AIDS or HIV or use of immunosuppressive medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dy Dermatology

Glenview, Illinois, United States, 60025

Actively Recruiting

2

Cynosure Lutronic

Westford, Massachusetts, United States, 01886

Actively Recruiting

Loading map...

Research Team

C

Charlotte Antoni Clinical Research Coordinator

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here